Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4229235
Max Phase: Preclinical
Molecular Formula: C19H22FN3O
Molecular Weight: 327.40
Molecule Type: Small molecule
Associated Items:
ID: ALA4229235
Max Phase: Preclinical
Molecular Formula: C19H22FN3O
Molecular Weight: 327.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(C)C(C(=O)NCCNc2cccnc2)C1c1ccc(F)cc1
Standard InChI: InChI=1S/C19H22FN3O/c1-19(2)16(13-5-7-14(20)8-6-13)17(19)18(24)23-11-10-22-15-4-3-9-21-12-15/h3-9,12,16-17,22H,10-11H2,1-2H3,(H,23,24)
Standard InChI Key: HAXGNYYTUSFHDY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 327.40 | Molecular Weight (Monoisotopic): 327.1747 | AlogP: 3.19 | #Rotatable Bonds: 6 |
Polar Surface Area: 54.02 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 5.54 | CX LogP: 2.18 | CX LogD: 2.18 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.80 | Np Likeness Score: -0.91 |
1. Nair RR, Geldenhuys WJ, Piktel D, Sadana P, Gibson LF.. (2018) Novel compounds that target lipoprotein lipase and mediate growth arrest in acute lymphoblastic leukemia., 28 (10): [PMID:29650292] [10.1016/j.bmcl.2018.03.061] |
Source(1):